High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes

Journal of Cellular Biochemistry

Volumn 112, Issue 6, 2011, Pages 1661-1672

  Piwkowska, Agnieszka ^a   Rogacka, Dorota ^a   Audzeyenka, Irena ^a   Jankowski, MacIej ^a,b   Angielski, Stefan ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

catalase; gluthatione peroxidase; high glucose; NAD(P)H oxidase; podocytes; reactive oxygen species; superoxide dismutase

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; GLUCOSE; GLUTATHIONE PEROXIDASE; MICE; OXIDANTS; OXIDATIVE STRESS; PODOCYTES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 79954546899     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23088     Document Type: Article

References (44)

1. Aebi H,. 1984. Catalase in vitro. Methods Enzymol 105: 121-126.
2. Blézquez-Medela AM, Lõpez-Novoa JM, Martínez-Salgado C,. 2010. Mechanisms involved in the genesis of diabetic nephropathy. Curr Diabetes Rev 6: 68-87.
3. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS,. 2007. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 71: 912-923. (Pubitemid 46663797)
4. Brown DI, Griendling KK,. 2009. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253.
5. Brown-Borg HM, Rakoczy SG,. 2000. Catalase expression in delayed and premature aging mouse models. Exp Gerontol 35: 199-212. (Pubitemid 30190085)
6. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schröder E, Browning DD, Eaton P,. 2007. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317: 1393-1397. (Pubitemid 47417480)
7. Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER,. 2002. Glucose-induced oxidative stress in mesangial cells. Kidney Int 61: 599-608. (Pubitemid 34102602)
8. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE,. 2009. Mechanisms of podocyte injury in diabetes: Role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211.
9. Forbes JM, Coughlan MT, Cooper ME,. 2008. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454.
10. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE,. 2005. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626. (Pubitemid 41713921)
11. Gõth L,. 2008. Catalase deficiency and type 2 diabetes. Diabetes Care 31: e93.
12. Greiber S, Münzel T, Kästner S, Müller B, Schollmeyer P, Pavenstädt H,. 1998. NAD(P)H oxidase activity in cultured human podocytes: Effects of adenosine triphosphate. Kidney Int 53: 654-663. (Pubitemid 28124280)
13. Kakehi T, Yabe-Nishimura C,. 2008. NOX enzymes and diabetic complications. Semin Immunopathol 30: 301-314.
14. Kakkar R, Kalra J, Mantha SV, Prasad K,. 1995. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119.
15. Kang YJ, Chen Y, Epstein PN,. 1996. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271: 12610-12616. (Pubitemid 26160936)
16. Kim NH, Rincon-Choles H, Bhandari B, Choudhury GG, Abboud HE, Gorin Y,. 2006. Redox dependence of glomerular epithelial cell hypertrophy in response to glucose. Am J Physiol Renal Physiol 290: F741-F751. (Pubitemid 43724977)
17. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H,. 2003. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245. (Pubitemid 36903933)
18. Limaye PV, Raghuram N, Sivakami S,. 2003. Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem 243: 147-152. (Pubitemid 36240562)
19. Marklund SL,. 1984. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 74: 1398-1403. (Pubitemid 15206836)
20. Matés JM, Pérez-Gõmez C, Núñez de Castro I,. 1999. Antioxidant enzymes and human diseases. Clin Biochem 32: 595-603.
21. Michiels C, Raes M, Toussaint O, Remacle J,. 1994. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17: 235-248.
22. Mogensen CE,. 2003. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 254: 45-66. (Pubitemid 36819130)
23. Mohanty JG, Jaffe JS, Schulman ES, Raible DG,. 1997. A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods 202: 133-141. (Pubitemid 27128755)
24. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R,. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258. (Pubitemid 27452369)
25. Münzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG,. 1996. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J Clin Invest 98: 1465-1470. (Pubitemid 26322073)
26. Münzel T, Afanas'ev IB, Kleschyov AL, Harrison DG,. 2002. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 22: 1761-1768. (Pubitemid 35315760)
27. Nath KA, Fischereder M, Hostetter TH,. 1994. The role of oxidants in progressive renal injury. Kidney Int 45: S111-S115.
28. Nauseef WM,. 2008. Biological roles for the NOX family NADPH oxidases. J Biol Chem 283: 16961-16965.
29. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D,. 1993. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90: 3645-3649. (Pubitemid 23111424)
30. Onozato ML, Tojo A,. 2005. Role of NADPH Oxidase in hypertension and diabetic nephropathy. Curr Hypertens Rev 1: 15-20.
31. Paglia DE, Valentine WN,. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
32. Piwkowska A, Rogacka D, Jankowski M, Dominiczak MH, Stȩpiń ski JK, Angielski S,. 2010. Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochem Biophys Res Commun 393: 268-273.
33. Ren G, Huynh C, Bijian K, Cybulsky AV,. 2008. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Mol Immunol 45: 2236-2246.
34. Rhee SG,. 2006. Cell signaling. H2O2, a necessary evil for cell signaling. Science 312: 1882-1883. (Pubitemid 43993698)
35. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E,. 1997. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40: 23-29. (Pubitemid 27035706)
36. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Fõrrõ L, Schlegel W, Krause KH,. 2007. NOX4 activity is determined by mRNA levels and reveals a unique patter of ROS generation. Biochem J 406: 105-114. (Pubitemid 47264740)
37. Shah SV,. 1989. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106. (Pubitemid 19167894)
38. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ,. 2008. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656. (Pubitemid 351632369)
39. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakatas H, Naito S, Hattori M, Sakaki Y, Sumimoto H,. 2001. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276: 1417-1423. (Pubitemid 32096573)
40. Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, Mossman BT,. 1991. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 266: 24398-24403. (Pubitemid 21908955)
41. Soberman RJ,. 2003. The expanding network of redox signaling: New observations, complexities, and perspectives. J Clin Invest 111: 571-574. (Pubitemid 36278572)
42. Susztak K, Raff AC, Schiffer M, Böttinger EP,. 2006. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55: 225-233. (Pubitemid 43343319)
43. Tagami S, Kondo T, Yoshida K, Hirokawa J, Ohtsuka Y, Kawakami Y,. 1992. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism 41: 1053-1058.
44. Ukeda H, Maeda S, Ishii T, Sawamura M,. 1997. Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3'-1-(phenylamino)-carbonyl- 3, 4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase. Anal Biochem 251: 206-209. (Pubitemid 27392679)